Silvia Govi

Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

Andrea Rinaldi, Michael Mian, Ekaterina Chigrinova et al. · Blood · 2010 · 188 citations · Full text

Medicine, Molecular Biology, Oncology +17

<i>Chlamydophila Psittaci</i> Eradication With Doxycycline As First-Line Targeted Therapy for Ocular Adnexae Lymphoma: Final Results of an International Phase II Trial

Andrés J.M. Ferreri, Silvia Govi, Elisa Pasini et al. · Journal of Clinical Oncology · 2012 · 168 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas

Andrés J.M. Ferreri, Emilio Guerra, Mario Regazzi et al. · British Journal of Cancer · 2004 · 153 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma

Andrés J.M. Ferreri, Elı́as Campo, A. Ambrosetti et al. · Annals of Oncology · 2004 · 122 citations · Full text

Medicine, Oncology, Pharmacology +13

Risk‐tailored <scp>CNS</scp> prophylaxis in a mono‐institutional series of 200 patients with diffuse large B‐cell lymphoma treated in the rituximab era

Andrés J.M. Ferreri, Marta Bruno‐Ventre, Giovanni Donadoni et al. · British Journal of Haematology · 2014 · 107 citations · Full text

Medicine, Oncology, Pharmacotherapy +15